Physician profile
Suzanne Nogami
NPI 1720304595
$3,009.74
in general payments reported to CMS, 2019-2025
36 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,026 · 2020: $318 · 2021: $702 · 2022: $502 · 2023: $340 · 2024: $122.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $462.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $462.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $720.35 | 2019-2023 | |
| Applied Medical Resources Corporation | $406.19 | 2019 | |
| Exeltis, USA INC. | $279.34 | 2019-2021 | |
| Therapeuticsmd, INC. | $251.10 | 2019-2022 | |
| Allergan, INC. | $155.01 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $119.88 | 2019-2023 | |
| Coopersurgical, INC. | $92.72 | 2021-2024 | Paragard T 380a, Paragard T 380a |
| Lupin INC. | $92.11 | 2019-2020 | |
| Evofem Biosciences, INC. | $82.43 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $76.89 | 2022-2023 | |
| Conmed Corporation | $74.00 | 2019 | |
| Pfizer INC. | $61.30 | 2022-2023 | |
| Hologic Sales and Service, LLC | $59.30 | 2024 | Aptima |
| Amag Pharmaceuticals, INC. | $42.24 | 2019-2020 | |
| Smith+Nephew, INC. | $40.76 | 2019-2020 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $38.82 | 2022 | |
| Astellas Pharma US INC | $36.94 | 2019 | |
| Sumitomo Pharma America, INC. | $35.58 | 2023-2024 | Myfembree |
| Millicent US INC | $31.22 | 2019-2020 | |
| Amgen INC. | $30.89 | 2020-2021 | |
| Duchesnay USA Incorporated | $30.75 | 2019 | |
| Merck Sharp & Dohme LLC | $28.80 | 2019-2023 | Belsomra |
| Radius Health, INC. | $25.32 | 2023 | Tymlos |
| Exact Sciences Corporation | $22.08 | 2024 | Cologuard Collection Kit |
| Urovant Sciences INC | $18.80 | 2022 | |
| Renovia INC | $18.12 | 2021 | |
| Roche Diagnostics Corporation | $18.08 | 2021 | |
| Medicem INC. | $16.34 | 2020 | |
| Trevena, INC. | $15.45 | 2021 | |
| Agile Therapeutics, INC. | $15.37 | 2021 | |
| Organon LLC | $14.20 | 2021 | |
| Avion Pharmaceuticals | $13.71 | 2021 | |
| Mission Pharmacal Company | $12.07 | 2019 | |
| Mylan Pharmaceuticals INC. | $11.97 | 2021 | |
| Novo Nordisk INC | $11.60 | 2019 | |
| Aspira Women'S Health INC | $10.01 | 2023 | Ova1 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suzanne Nogami listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.